Dear Sir, Tuberculosis is a relatively common infectious disease among hemodialysis patients and is usually related to Mycobacterium tuber-culosis¦¦., 2]. Infections due to other mycobac-teria are exceptional in these patients [3]. We observed a disseminated mycobacterial infection due to M. kansasii in a patient dialyzed for 4 years. A 63-year-old Caucasian man suffered from psychosis and type II diabetes with hypertension and end-stage renal failure. During the past 4 years, he had been dialyzed three times weekly for 4 h without major complications. Then he developed fever up to 39 °C with poor appetite and loss of weight and was hospitalized. On admission, he had high grade fever with cardiac insufficiency and edemas. The liver was enlarged. There was no peripheral lymphadenopathy. Widespread cutaneous infection linked to severe pruritus was prominent. A tuberculin test was negative. Chest X-ray showed a reticular infiltrate of the right subclavian region with a frank cardiomegaly. Laboratory data showed a white cell count of 9 × 109/1 with 76% polymorphonuclear leukocytes. The erythrocyte sedimentation rate was 105 mm/h. Total serum protein was 6.4 g/dl, serum albumin was 3.2 g/dl, and serum γ-globulin was 1.6 g/dl. Serum aminotransferase and bilirubin were normal. Serum γ-gluta-myltransferase and alkaline phosphatase were twice the upper limit of normal values. Tests for HBsAg, hepatitis C, and HIV were negative. Sputum and gastric juice were negative on smear for acid-fast bacilli (AFB), and cultures were set up. Blood cultures yielded no growths. Echocardiography showed a non-obstructive cardiomyopathy without valvular disease. An abdominal CT-scan was normal. The patient received isoniazid 350 mg, rifampicin 600 mg and ethambutol 600 mg. Because of the cutaneous infection, vanco-mycin was added to this regimen for 15 days. Two months later, two cultures of gastric juice gave growths of AFB identified as M. kansasii; this microorganism was sensitive to the antibiotics prescribed. Treatment was continued with isoniazid 250 mg after each dialysis session, rifampicin 600 mg daily and ethambutol 600 mg after dialysis and 400 mg daily between the dialysis sessions. However, the patient remained severely ill and febrile, and cardiac failure persisted. Chest X-ray did not improve. He
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